2011. Gilet H et al. – In response to McKenna and John Brodersen’s letter to editor. Application of the disease-specific quality of life assessment of growth hormone deficiency in adults (QOL-AGHDA) questionnaire in a general population: Results from a French panel study

 

Gilet H, Viala-Danten M, Koltowska-Haggstrom. In response to McKenna and John Brodersen’s letter to editor. Application of the disease-specific quality of life assessment of growth hormone deficiency in adults (QOL-AGHDA) questionnaire in a general population: Results from a French panel study. Value health. 2011;14(4):619-20.

Full article link

Abstract

We are grateful for having the opportunity to reply to the letter from Stephen McKenna and John Brodersen [1], in which the authors discuss several issues related to our work. Our study was intended to pursue the work begun by others to provide normative data on the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA) questionnaire to help interpret QoL-AGHDA data collected in growth hormone deficient (GHD) patients. In this context, we aimed to complete previous studies that enabled reference values for the QoL-AGHDA questionnaire to be collected in general populations in European countries [2–6].